{"id":1749,"date":"2020-08-14T02:23:10","date_gmt":"2020-08-14T02:23:10","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1749"},"modified":"2023-08-29T18:02:00","modified_gmt":"2023-08-29T18:02:00","slug":"mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1749","title":{"rendered":"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891"},"content":{"rendered":"<p>\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=MSB&amp;lang=cn\">Mesoblast (ASX: MSB)<\/a>\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002<\/p>\n<p>FDA\u4ee59\u6bd41\u7684\u6295\u7968\u7ed3\u679c\u652f\u6301remestemcel-L\u5bf9\u60a3\u6709\u7c7b\u56fa\u9187\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(SR-AGVHD)\u7684\u513f\u7ae5\u7684\u7597\u6548\u3002<\/p>\n<p>\u8fd9\u5bf9\u8be5\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u79cd\u6e29\u6696\u7684\u5b89\u6170\uff0c\u672c\u5468\u8be5\u516c\u53f8\u7684\u4ef7\u503c\u4e0b\u8dcc\u4e86\u4e09\u5206\u4e4b\u4e00\uff0c\u56e0\u4e3a\u6709\u6d88\u606f\u79f0\uff0cFDA\u5e0c\u671b\u201c\u8ba8\u8bba\u4e0eremestemcel-L\u7684\u7279\u5f81\u548c\u5173\u952e\u8d28\u91cf\u5c5e\u6027\u6709\u5173\u7684\u95ee\u9898\u201d\u3002<\/p>\n<h2>\u63a8\u52a8Ryoncil\u5546\u4e1a\u5316<\/h2>\n<p>\u540d\u4e3aRyoncil\u7684remestemcel-L\u662fMesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\uff0c\u8be5\u516c\u53f8\u4eca\u5e74\u80af\u5b9a\u5728\u4e3a\u6b64\u5fd9\u5f97\u4e0d\u53ef\u5f00\u4ea4\u3002<\/p>\n<p>\u4eca\u5e745\u6708\uff0c\u8be5\u516c\u53f8\u900f\u9732\uff0c\u5b83\u6b63\u5728\u5229\u7528\u65b0\u7684\u8d44\u672c\uff0c\u4f7f\u8ba1\u5212\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5728\u7f8e\u56fd\u8fdb\u884c\u7684\u5546\u4e1a\u542f\u52a8\u6210\u4e3a\u53ef\u80fd\u3002<\/p>\n<p>1.38\u4ebf\u6fb3\u5143\u7684\u8d44\u91d1\u8fd8\u7528\u4e8e\u5bf9\u5df2\u53d1\u5c55\u4e3a\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u51a0\u72b6\u75c5\u6bd2\u91cd\u75c7\u60a3\u8005\u4f7f\u7528remestemcel-L\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u7136\u800c\uff0c\u4eca\u5929\u7684\u65b0\u95fb\u4ec5\u4ec5\u662f\u5173\u4e8e\u5b83\u5728\u60a3\u6709\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u7684\u513f\u7ae5\u4e2d\u7684\u5e94\u7528\u3002<\/p>\n<p>Mesoblast\u7684\u9996\u5e2d\u533b\u7597\u5b98Fred Grossman\u535a\u58eb\u5bf9\u6295\u8d44\u8005\u8bf4:\u201c\u6fc0\u7d20\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u662f\u4e00\u4e2a\u975e\u5e38\u9700\u8981\u7684\u9886\u57df\uff0c\u7279\u522b\u662f\u5bf9\u4e8e12\u5c81\u4ee5\u4e0b\u7684\u6613\u611f\u513f\u7ae5\uff0c\u4ed6\u4eec\u8fd8\u6ca1\u6709\u5f97\u5230\u6279\u51c6\u7684\u6cbb\u7597\u3002\u201d<\/p>\n<p>\u201c\u6211\u4eec\u5bf9\u4eca\u5929\u7684\u7ed3\u679c\u611f\u5230\u975e\u5e38\u9f13\u821e\uff0c\u5e76\u81f4\u529b\u4e8e\u4e0eFDA\u5bc6\u5207\u5408\u4f5c\uff0c\u56e0\u4e3a\u4ed6\u4eec\u5b8c\u6210\u4e86\u5bf9\u6211\u4eec\u63d0\u4ea4\u7684\u5173\u4e8eRyoncil\u5bf9\u8fd9\u79cd\u5371\u53ca\u751f\u547d\u7684\u5f02\u4f53\u9aa8\u9ad3\u79fb\u690d\u5e76\u53d1\u75c7\u7684\u5ba1\u6279\u3002\u201d<\/p>\n<p>\u675c\u514b\u5927\u5b66\u533b\u5b66\u4e2d\u5fc3(Duke University Medical Center)\u7684\u513f\u79d1\u79fb\u690d\u533b\u751fJoanne Kurtzberg\u5bf9 remestemcel-L\u7684\u6f5c\u529b\u975e\u5e38\u770b\u597d\u3002<\/p>\n<p>\u201c\u8fd9\u79cd\u6bc1\u706d\u6027\u7684\u75be\u75c5\u9884\u540e\u6781\u5dee\uff0c\u800c\u4e14FDA\u8fd8\u6ca1\u6709\u6279\u51c6\u5bf912\u5c81\u4ee5\u4e0b\u513f\u7ae5\u7684\u6cbb\u7597\u65b9\u6848\u3002\u6211\u6307\u5bfc\u7684\u4e34\u5e8a\u7814\u7a76\u5df2\u7ecf\u8bc1\u660e\u4e86\u8fd9\u79cd\u7597\u6cd5\u7684\u6f5c\u529b\uff0c\u53ef\u4ee5\u6ee1\u8db3\u4e00\u4e2a\u91cd\u5927\u7684\u672a\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\uff0c\u201d\u5979\u8bf4\u3002<\/p>\n<p>\u63a5\u4e0b\u6765\u7684\u6b65\u9aa4\u8981\u6c42FDA\u5728\u4e5d\u6708\u5e95\u6839\u636e\u5904\u65b9\u836f\u4f7f\u7528\u8005\u6536\u8d39\u6cd5\u6848\u6279\u51c6\u8be5\u836f\u7269\u3002<\/p>\n<p>\u4eca\u5e745\u6708\uff0c\u8be5\u516c\u53f8\u5728\u5168\u7403\u8fdb\u884c\u4e861.38\u4ebf\u6fb3\u5143\u7684\u5927\u89c4\u6a21\u878d\u8d44\uff0c\u76ee\u524d\u62e5\u67091.88\u4ebf\u6fb3\u5143\u73b0\u91d1\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002 FDA\u4ee59\u6bd41\u7684\u6295\u7968\u7ed3\u679c\u652f\u6301remestemcel-L\u5bf9\u60a3\u6709\u7c7b\u56fa\u9187\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5(SR-AGVHD)\u7684\u513f\u7ae5\u7684\u7597\u6548\u3002 \u8fd9\u5bf9\u8be5\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u79cd\u6e29\u6696\u7684\u5b89\u6170\uff0c\u672c\u5468\u8be5\u516c\u53f8\u7684\u4ef7\u503c\u4e0b\u8dcc\u4e86\u4e09\u5206\u4e4b\u4e00\uff0c\u56e0\u4e3a\u6709\u6d88\u606f\u79f0\uff0cFDA\u5e0c\u671b\u201c\u8ba8\u8bba\u4e0eremestemcel-L\u7684\u7279\u5f81\u548c\u5173\u952e\u8d28\u91cf\u5c5e\u6027\u6709\u5173\u7684\u95ee\u9898\u201d\u3002 \u63a8\u52a8Ryoncil\u5546\u4e1a\u5316 \u540d\u4e3aRyoncil\u7684remestemcel-L\u662fMesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\uff0c\u8be5\u516c\u53f8\u4eca\u5e74\u80af\u5b9a\u5728\u4e3a\u6b64\u5fd9\u5f97\u4e0d\u53ef\u5f00\u4ea4\u3002 \u4eca\u5e745\u6708\uff0c\u8be5\u516c\u53f8\u900f\u9732\uff0c\u5b83\u6b63\u5728\u5229\u7528\u65b0\u7684\u8d44\u672c\uff0c\u4f7f\u8ba1\u5212\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5728\u7f8e\u56fd\u8fdb\u884c\u7684\u5546\u4e1a\u542f\u52a8\u6210\u4e3a\u53ef\u80fd\u3002 1.38\u4ebf\u6fb3\u5143\u7684\u8d44\u91d1\u8fd8\u7528\u4e8e\u5bf9\u5df2\u53d1\u5c55\u4e3a\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u7684\u51a0\u72b6\u75c5\u6bd2\u91cd\u75c7\u60a3\u8005\u4f7f\u7528remestemcel-L\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u7136\u800c\uff0c\u4eca\u5929\u7684\u65b0\u95fb\u4ec5\u4ec5\u662f\u5173\u4e8e\u5b83\u5728\u60a3\u6709\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u7684\u513f\u7ae5\u4e2d\u7684\u5e94\u7528\u3002 Mesoblast\u7684\u9996\u5e2d\u533b\u7597\u5b98Fred Grossman\u535a\u58eb\u5bf9\u6295\u8d44\u8005\u8bf4:\u201c\u6fc0\u7d20\u96be\u6cbb\u6027\u6025\u6027\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\u662f\u4e00\u4e2a\u975e\u5e38\u9700\u8981\u7684\u9886\u57df\uff0c\u7279\u522b\u662f\u5bf9\u4e8e12\u5c81\u4ee5\u4e0b\u7684\u6613\u611f\u513f\u7ae5\uff0c\u4ed6\u4eec\u8fd8\u6ca1\u6709\u5f97\u5230\u6279\u51c6\u7684\u6cbb\u7597\u3002\u201d \u201c\u6211\u4eec\u5bf9\u4eca\u5929\u7684\u7ed3\u679c\u611f\u5230\u975e\u5e38\u9f13\u821e\uff0c\u5e76\u81f4\u529b\u4e8e\u4e0eFDA\u5bc6\u5207\u5408\u4f5c\uff0c\u56e0\u4e3a\u4ed6\u4eec\u5b8c\u6210\u4e86\u5bf9\u6211\u4eec\u63d0\u4ea4\u7684\u5173\u4e8eRyoncil\u5bf9\u8fd9\u79cd\u5371\u53ca\u751f\u547d\u7684\u5f02\u4f53\u9aa8\u9ad3\u79fb\u690d\u5e76\u53d1\u75c7\u7684\u5ba1\u6279\u3002\u201d \u675c\u514b\u5927\u5b66\u533b\u5b66\u4e2d\u5fc3(Duke University Medical Center)\u7684\u513f\u79d1\u79fb\u690d\u533b\u751fJoanne Kurtzberg\u5bf9 remestemcel-L\u7684\u6f5c\u529b\u975e\u5e38\u770b\u597d\u3002 \u201c\u8fd9\u79cd\u6bc1\u706d\u6027\u7684\u75be\u75c5\u9884\u540e\u6781\u5dee\uff0c\u800c\u4e14FDA\u8fd8\u6ca1\u6709\u6279\u51c6\u5bf912\u5c81\u4ee5\u4e0b\u513f\u7ae5\u7684\u6cbb\u7597\u65b9\u6848\u3002\u6211\u6307\u5bfc\u7684\u4e34\u5e8a\u7814\u7a76\u5df2\u7ecf\u8bc1\u660e\u4e86\u8fd9\u79cd\u7597\u6cd5\u7684\u6f5c\u529b\uff0c\u53ef\u4ee5\u6ee1\u8db3\u4e00\u4e2a\u91cd\u5927\u7684\u672a\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\uff0c\u201d\u5979\u8bf4\u3002 \u63a5\u4e0b\u6765\u7684\u6b65\u9aa4\u8981\u6c42FDA\u5728\u4e5d\u6708\u5e95\u6839\u636e\u5904\u65b9\u836f\u4f7f\u7528\u8005\u6536\u8d39\u6cd5\u6848\u6279\u51c6\u8be5\u836f\u7269\u3002 \u4eca\u5e745\u6708\uff0c\u8be5\u516c\u53f8\u5728\u5168\u7403\u8fdb\u884c\u4e861.38\u4ebf\u6fb3\u5143\u7684\u5927\u89c4\u6a21\u878d\u8d44\uff0c\u76ee\u524d\u62e5\u67091.88\u4ebf\u6fb3\u5143\u73b0\u91d1\u3002<\/p>\n","protected":false},"author":5,"featured_media":8996,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[95],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891<\/title>\n<meta name=\"description\" content=\"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891\" \/>\n<meta property=\"og:description\" content=\"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-14T02:23:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Mesoblast-ASX-MSB-Oncologic-Drugs-Advisory-Committee-ODAC-remestemcel-L-RYONCIL.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891\" \/>\n<meta name=\"twitter:description\" content=\"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Mesoblast-ASX-MSB-Oncologic-Drugs-Advisory-Committee-ODAC-remestemcel-L-RYONCIL.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/\",\"name\":\"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-08-14T02:23:10+00:00\",\"dateModified\":\"2023-08-29T18:02:00+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891","description":"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891","og_description":"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/","og_site_name":"smallcapsCN","article_published_time":"2020-08-14T02:23:10+00:00","article_modified_time":"2023-08-29T18:02:00+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Mesoblast-ASX-MSB-Oncologic-Drugs-Advisory-Committee-ODAC-remestemcel-L-RYONCIL.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891","twitter_description":"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Mesoblast-ASX-MSB-Oncologic-Drugs-Advisory-Committee-ODAC-remestemcel-L-RYONCIL.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/","url":"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/","name":"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-08-14T02:23:10+00:00","dateModified":"2023-08-29T18:02:00+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u5728\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5bf9remestemcel-L\u6295\u8d5e\u6210\u7968\u540e\uff0c\u6fb3\u5927\u5229\u4e9a\u751f\u7269\u6280\u672f\u4e2d\u76d8Mesoblast (ASX: MSB)\u7684\u80a1\u4ef7\u4eca\u5929\u8fbe\u5230\u516d\u5e74\u591a\u6765\u7684\u6700\u9ad8\u70b9\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/mesoblast-lead-drug-candidate-achieves-major-regulatory-milestone-us-fda-vote\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Mesoblast\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269\u5728\u7f8e\u56fdFDA\u6295\u7968\u540e\u53d6\u5f97\u4e86\u91cd\u5927\u7684\u76d1\u7ba1\u91cc\u7a0b\u7891"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1749"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1749"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1749\/revisions"}],"predecessor-version":[{"id":8995,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1749\/revisions\/8995"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/8996"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}